Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew D Dick

Showing results (91-100 of 245) with videos related to

Pageof 25
Sort By:
Frontiers in Pediatrics|July 8, 2022
Development of a Nationally Agreed Core Clinical Dataset for Childhood Onset UveitisAmeenat Lola Solebo, Salomey Kellett, Jugnoo Rahi, et al.
Ocular Immunology and Inflammation|December 21, 2012
Behçet disease-associated uveitis successfully treated with golimumabMarina Mesquida, María Victoria Hernández, Victor Llorenç, et al.
Scientific Reports|November 23, 2016
An anti-TNF-α antibody mimetic to treat ocular inflammationHanieh Khalili, Richard W Lee, Peng T Khaw, et al.
International Ophthalmology|April 1, 2017
Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitisGeorgios Makragiannis, Kaveh Vahdani, Ester Carreño, et al.
The British Journal of Ophthalmology|September 16, 2006
Validity of using vision-related quality of life as a treatment end point in intermediate and posterior uveitisConor C Murphy, Kathrin Greiner, Jarka Plskova, et al.
International Ophthalmology|June 5, 2013
Current and future treatments for Behçet's uveitis: road to remissionMarina Mesquida, Blanca Molins, Victor Llorenç, et al.
Experimental Eye Research|December 3, 2014
Local targeting of the CD200-CD200R axis does not promote corneal graft survivalSusan M Nicholls, David A Copland, Andrea Vitova, et al.
Immunobiology|August 10, 2010
IL-10 regulation of macrophage VEGF production is dependent on macrophage polarisation and hypoxiaWei-Kang Wu, Oliver P C Llewellyn, David O Bates, et al.
Experimental Eye Research|September 6, 2021
Peptide-based immunotherapy against oxidized elastin ameliorates pathology in mouse model of smoke-induced ocular injuryBärbel Rohrer, Nathaniel Parsons, Balasubramaniam Annamalai, et al.
Investigative Ophthalmology & Visual Science|April 3, 2009
Steroid refractory CD4+ T cells in patients with sight-threatening uveitisRichard W J Lee, Lauren P Schewitz, Lindsay B Nicholson, et al.
Pageof 25

Showing results (91-100 of 245) with videos related to

Sort By:
Pageof 25
Frontiers in Pediatrics|July 8, 2022
Development of a Nationally Agreed Core Clinical Dataset for Childhood Onset UveitisAmeenat Lola Solebo, Salomey Kellett, Jugnoo Rahi, et al.
Ocular Immunology and Inflammation|December 21, 2012
Behçet disease-associated uveitis successfully treated with golimumabMarina Mesquida, María Victoria Hernández, Victor Llorenç, et al.
Scientific Reports|November 23, 2016
An anti-TNF-α antibody mimetic to treat ocular inflammationHanieh Khalili, Richard W Lee, Peng T Khaw, et al.
International Ophthalmology|April 1, 2017
Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitisGeorgios Makragiannis, Kaveh Vahdani, Ester Carreño, et al.
The British Journal of Ophthalmology|September 16, 2006
Validity of using vision-related quality of life as a treatment end point in intermediate and posterior uveitisConor C Murphy, Kathrin Greiner, Jarka Plskova, et al.
International Ophthalmology|June 5, 2013
Current and future treatments for Behçet's uveitis: road to remissionMarina Mesquida, Blanca Molins, Victor Llorenç, et al.
Experimental Eye Research|December 3, 2014
Local targeting of the CD200-CD200R axis does not promote corneal graft survivalSusan M Nicholls, David A Copland, Andrea Vitova, et al.
Immunobiology|August 10, 2010
IL-10 regulation of macrophage VEGF production is dependent on macrophage polarisation and hypoxiaWei-Kang Wu, Oliver P C Llewellyn, David O Bates, et al.
Experimental Eye Research|September 6, 2021
Peptide-based immunotherapy against oxidized elastin ameliorates pathology in mouse model of smoke-induced ocular injuryBärbel Rohrer, Nathaniel Parsons, Balasubramaniam Annamalai, et al.
Investigative Ophthalmology & Visual Science|April 3, 2009
Steroid refractory CD4+ T cells in patients with sight-threatening uveitisRichard W J Lee, Lauren P Schewitz, Lindsay B Nicholson, et al.
Pageof 25